| Literature DB >> 21856306 |
Conrad E Z Chan1, Annie H Y Chan, Angeline P C Lim, Brendon J Hanson.
Abstract
Rapid development of diagnostic immunoassays against novel emerging or genetically modified pathogens in an emergency situation is dependent on the timely isolation of specific antibodies. Non-immune antibody phage display libraries are an efficient in vitro method for selecting monoclonal antibodies and hence ideal in these circumstances. Such libraries can be constructed from a variety of sources e.g. B cell cDNA orEntities:
Mesh:
Substances:
Year: 2011 PMID: 21856306 PMCID: PMC7094349 DOI: 10.1016/j.jim.2011.08.005
Source DB: PubMed Journal: J Immunol Methods ISSN: 0022-1759 Impact factor: 2.303
Fig. 1Screening of Tomlinson scFv libraries against PA. (A) Polyclonal ELISA of Tom I and J phage pans against PA showing enrichment for PA-binding clones. (B) Number of total screened, positive (OD > 0.5) and unique clones (as determined by sequencing of variable regions) obtained. (C) CDR sequences of identified unique clones. Bold residues indicate amber stop and underline indicates putative N-linked glycosylation sites. (D–F) Monoclonal ELISA of anti-PA clones isolated from Tomlinson I and J scFv libraries in various formats as (D) scFv-phage particles (E) soluble scFv dimers (F) purified full-length IgG, showing high affinity and specify as phage but loss of either affinity and/or specificity after expression as soluble scFv or IgG. Prefix (m) before the clone name indicates clones which had their amber stop codon changed to glutamic acid so prevent premature termination of translation. 5% BSA is 5% bovine serum albumin in PBS used as an antigen negative control. Culture media or irrelevant antibody was used as a clone negative control. (G) Reduced comassie gel of purified IgG showing heavy (Hc) and light chains (Lc).
Fig. 2Screening of Tomlinson scFv libraries against Etox. (A) Polyclonal phage ELISA showing enrichment for Etox-binding clones. (B) Number of total screened, positive (OD > 0.5) and unique clones (as determined by sequencing of variable regions) obtained. Due to the low number of positive clones with OD > 0.5, additional weaker clones were screened to give additional unique clones (C) CDR sequences of identified unique clones. Bold residues indicate amber stop and underline indicates putative N-linked glycosylation site. Numerous clones contain either stop codons and glycosylation sites.
Fig. 3Screening of Humanyx library against PA and Etox. (A) Polyclonal phage ELISA showing specific enrichment with subsequent pans for both PA and Etox antigens (B) number of total screened, positive (OD > 0.5) and unique clones (as determined by sequencing of variable regions) obtained. For the Etox library only clones OD > 1.0 were selected for further screening due to the large number of positives. (C) Monoclonal ELISA of selected anti-PA and Etox clones showing 100% retention of high affinity and specificity after conversion to IgG from Fab.
Fig. 4Rapid screening of sandwich ELISA antibody pairs. Selected anti-PA IgG antibodies from the Fab (A) and synthetic scFv (B) libraries, as well as anti-Etox IgG antibodies from the Fab library (C) in all possible pairings as capture vs detector antibody (IgG vs IgG-bio or IgG vs IgG-HRP) for use in sandwich ELISA with 3 μg/ml PA or Etox antigen. 5% BSA is 5% bovine serum albumin in PBS used as an antigen negative control.
Fig. 5Determination of the limit of sensitivity of selected antibody pairs against PA and Etox. The lower limit of detection was determined for the indicated anti-PA IgG pairs from the Fab (A) and synthetic scFv (B) libraries, as well as anti-Etox pairs (C) from the Fab library in a sandwich ELISA using serially diluted PA or Etox antigen. Results shown are the average of three independent experiments with error bars showing standard error of mean. Signal-to-noise ratio is the ratio of the absorbance at the particular antigen concentration over the absorbance at 0 ng/ml concentration of antigen.